Using in vitro experiments, investigators found that anlotinib had significant effects on proliferation inhibition, migration and invasion restraint, and cell-cycle arrestment in intrahepatic cholangiocarcinoma.
[Cell Death & Disease]
6630899 H7XY3LA2 items 1 apa default asc 1
Song, F., Hu, B., Cheng, J.-W., Sun, Y.-F., Zhou, K.-Q., Wang, P.-X., Guo, W., Zhou, J., Fan, J., Chen, Z., & Yang, X.-R. (2020). Anlotinib suppresses tumor progression via blocking the VEGFR2/PI3K/AKT cascade in intrahepatic cholangiocarcinoma. Cell Death & Disease, 11(7), 1–14. https://doi.org/10.1038/s41419-020-02749-7 Cite
Scientists showed that LEFTY1, a secreted inhibitor of NODAL/SMAD2 signaling, was produced by mammary progenitor cells and, concomitantly, suppresses SMAD2 and SMAD5 signaling to promote long-term proliferation of normal and malignant mammary epithelial cells.
[Cell Stem Cell]
1254621 5PE8GSVS items 1 apa default asc 1
Scientists describe the immunoreceptor tyrosine-based inhibition motif-containing Fc gamma receptor IIb for being critical in leukemic stem cell resistance and showed that targeting FcγRIIb downstream signaling, by using a Food and Drug Administration-approved BTK inhibitor, provides a successful therapeutic approach.
1254621 4XUNGA8Z items 1 apa default asc 1
Researchers investigated the possible cytotoxic effects using normal BRL-3A and AML12 liver cells.
[Human & Experimental Toxicology]
1254621 PMAZL4ZL items 1 apa default asc 1
2F5 was confirmed to induce G0/G1 phase arrest in acute promyelocytic leukemia (APL) cells, and promoted APL cell differentiation combined with decreased DDX5 expression and increased reactive oxygen species production. Knockdown of DDX5 by siRNA also inhibited proliferation, promoted cell differentiation and enhanced ROS production in APL cells.
[Cell Death & Disease]
1254621 62KBMR3P items 1 apa default asc 1
Scientists showed that persistent antigenic stimulation impaired ADP-coupled oxidative phosphorylation.
1254621 87W3L5VJ items 1 apa default asc 1
In this study, the researchers performed intracranial injection using nine HER2-positive breast cancer cell lines to evaluate their proliferative activity in brain tissue.
6606345 KAY6LCLE items 1 apa default asc 1